Antiplatelet agents aspirin and dipyridamole, and the risk of different carcinoma in patients with type 2 diabetes mellitus: A Taiwan retrospective cohort study

Studies have shown aspirin decreases the risk of some cancers. However, the evidence reported the association between aspirin and cancer risk in the diabetic population. In this study, we investigate whether aspirin and dipyridamole decrease the risk of cancer in patients with type 2 diabetes. A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Hsing-Yi, Lu, Tz-Wen, Liang, Hsiu-Ling, Hsu, Wei-Hao, Sung, Ya-Wen, Lee, Mei-Yueh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478216/
https://www.ncbi.nlm.nih.gov/pubmed/36123870
http://dx.doi.org/10.1097/MD.0000000000030468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478216/
https://www.ncbi.nlm.nih.gov/pubmed/36123870
http://dx.doi.org/10.1097/MD.0000000000030468

Ejemplares similares